Brooke Shields' former home in the Pacific Palisades, which boasts five bedrooms and six bathrooms, is on the market for $8.6 ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

The global chocolate wrapping films market is poised for steady growth, with a projected average CAGR of 4.5% between 2023 ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...

Q3 2024 Earnings Call Transcript November 18, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx ...

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.

Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...

Volcanic activity will be experienced differently in a warmer world. Researchers need to understand these risks and how they could spiral.

The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...

President-elect Donald Trump taps RFK Jr. to run the Department of Health and Human Services. Here's why experts are worried.